Search Results

There are 31192 results for: content related to: CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura

  1. You have free access to this content
    WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS

    American Journal of Transplantation

    Volume 6, Issue s2, August 2006, Pages: 473–1061,

    Version of Record online : 11 AUG 2006, DOI: 10.1111/j.1600-6143.2006.01447.x

  2. You have free access to this content
    Abstracts

    American Journal of Transplantation

    Volume 5, Issue s11, May 2005, Pages: 155–576,

    Version of Record online : 12 MAY 2005, DOI: 10.1111/j.1600-6135.2005.abstracts.x

  3. A comparison of Campath and Thymoglobulin as part of the conditioning before allogeneic hematopoietic stem cell transplantation

    European Journal of Haematology

    Volume 86, Issue 1, January 2011, Pages: 57–66, Anna-Carin Norlin and Mats Remberger

    Version of Record online : 25 NOV 2010, DOI: 10.1111/j.1600-0609.2010.01537.x

  4. The CAMPATH-1 antigen (CDw52)

    Tissue Antigens

    Volume 35, Issue 3, March 1990, Pages: 118–127, Geoffrey Hale, Meng-Q. Xia, Helen P Tighe, Martin J. S. Dyer and Herman Waldmann

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1399-0039.1990.tb01767.x

  5. You have free access to this content
    American Transplant Congress 2007 Executive and Program Planning Committees and Abstract Review Committees

    American Journal of Transplantation

    Volume 7, Issue s2, May 2007, Pages: 17–584,

    Version of Record online : 26 APR 2007, DOI: 10.1111/j.1600-6143.2007.01811.x

  6. Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection

    Pediatric Transplantation

    Volume 16, Issue 3, May 2012, Pages: 286–293, Kiran Upadhyay, Laurie Midgley and Asha Moudgil

    Version of Record online : 24 NOV 2011, DOI: 10.1111/j.1399-3046.2011.01615.x

  7. You have free access to this content
    WORLD TRANSPLANT CONGRESS 2006 ORAL ABSTRACTS

    American Journal of Transplantation

    Volume 6, Issue s2, August 2006, Pages: 65–472,

    Version of Record online : 11 AUG 2006, DOI: 10.1111/j.1600-6143.2006.01446.x

  8. Campath-1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 38, Issue 11, November 1995, Pages: 1589–1594, Michael E. Weinblatt, Peter J. Maddison, Ken J. Bulpitt, Brian L. Hazleman, Murray B. Urowitz, Roger D. Sturrock, Jonathan S. Coblyn, Agnes L. Maier, William R. Spreen, Vasant K. Manna and Jeffrey M. Johnston

    Version of Record online : 9 DEC 2005, DOI: 10.1002/art.1780381110

  9. You have free access to this content
    The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment

    British Journal of Haematology

    Volume 107, Issue 1, October 1999, Pages: 148–153, Rawstron, Rollinson, Richards, Short, English, Morgan, Hale and Hillmen

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1999.01676.x

  10. Alemtuzumab (MabCampath)

    Handbook of Therapeutic Antibodies

    Thomas Elter, Andreas Engert, Michael Hallek, Pages: 733–777, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch28

  11. T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

    British Journal of Haematology

    Volume 89, Issue 3, March 1995, Pages: 506–515, E. Naparstek, R. Or, A. Nagler, G. Cividalli, D. Engelhard, M. Aker, Z. Gimon, N. Manny, T. Sacks, Z. Tochner, L. Weiss, S. Samuel, C. Brautbar, G. Hale, H. Waldmann, S. M. Steinberg and S. SLAVIN

    Version of Record online : 7 JUL 2008, DOI: 10.1111/j.1365-2141.1995.tb08356.x

  12. Clonal CD8+ and CD52 T cells are induced in responding B cell lymphoma patients treated with Campath-1H* (anti-CD52)

    European Journal of Haematology

    Volume 58, Issue 1, January 1997, Pages: 5–13, A. Österborg, Å. Werner, E. Halapi, J. Lundin, U. Harmenberg, H. Wigzell and H. Mellstedt

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1997.tb01403.x

  13. You have free access to this content
    Abstracts Poster

    American Journal of Transplantation

    Volume 8, Issue s2, May 2008, Pages: 337–637,

    Version of Record online : 23 APR 2008, DOI: 10.1111/j.1600-6143.2008.02255.x

  14. You have free access to this content
    Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material

    Clinical & Experimental Immunology

    Volume 87, Issue 1, January 1992, Pages: 105–110, J. S. CROWE, V. S. HALL, M. A. SMITH, H. J. COOPER and J. P. TITE

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2249.1992.tb06421.x

  15. Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 93, Issue 1, April 1996, Pages: 151–153, Anders ÖSterborg, Athanasios S. Fassas, Achilles Anagnostopoulos, Martin J. S. Dyer, Daniel Catovsky and Håkan Mellstedt

    Version of Record online : 2 OCT 2003, DOI: 10.1046/j.1365-2141.1996.450989.x

  16. Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

    European Journal of Immunology

    Volume 21, Issue 7, July 1991, Pages: 1677–1684, Meng-Qi Xia, Masahide Tone, Len Packman, Geoff Hale and Herman Waldmann

    Version of Record online : 13 DEC 2005, DOI: 10.1002/eji.1830210714

  17. You have free access to this content
    Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

    British Journal of Haematology

    Volume 96, Issue 3, March 1997, Pages: 617–619, A. L. Bowen, A. Zomas, E. Emmett, E. Matutes, M. J. S. Dyer and D. Catovsky

    Version of Record online : 29 OCT 2003, DOI: 10.1046/j.1365-2141.1997.d01-2061.x

  18. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

    Annals of Neurology

    Volume 46, Issue 3, September 1999, Pages: 296–304, Alasdair J. Coles, Mark G. Wing, Paul Molyneux, Andrea Paolillo, Charlie M. Davie, Geoff Hale, David Miller, Hermann Waldmann and Alastair Compston

    Version of Record online : 22 MAY 2001, DOI: 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#

  19. Specific cleavage of immunoglobulin G by copper ions

    International Journal of Peptide and Protein Research

    Volume 48, Issue 1, July 1996, Pages: 48–55, MARJORIE A SMITH, MARK EASTON, PETER EVERETT, GARNET LEWIS, MICHAEL PAYNE, VALENTINA RIVEROS-MORENO and GEOFFREY ALLEN

    Version of Record online : 12 JAN 2009, DOI: 10.1111/j.1399-3011.1996.tb01105.x

  20. You have free access to this content
    Abstracts (255 - 358)

    American Journal of Transplantation

    Volume 3, Issue s5, May 2003, Pages: 255–358,

    Version of Record online : 22 JUL 2008, DOI: 10.1034/j.1600-6143.3.s5.015a.x